Medium term fate of dura mater valvular bioprostheses
Eighty-two patients have been followed for a mean period of 29 months after implantation of dura mater valvular bioprostheses (60 mitral valves, 30 aortic valves and two tricuspid valves). There have been three late deaths, two related to reoperation and one to endocarditis. Severe hemolysis, infect...
Gespeichert in:
| Veröffentlicht in: | European heart journal 1980-06, Vol.1 (3), p.195-199 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 199 |
|---|---|
| container_issue | 3 |
| container_start_page | 195 |
| container_title | European heart journal |
| container_volume | 1 |
| creator | PERMANYER-MIRALDA, G. SOLER-SOLER, J. CASAN-CAVA, J. M. TORNOS-MAS, M. P. |
| description | Eighty-two patients have been followed for a mean period of 29 months after implantation of dura mater valvular bioprostheses (60 mitral valves, 30 aortic valves and two tricuspid valves). There have been three late deaths, two related to reoperation and one to endocarditis. Severe hemolysis, infective endocarditis and systemic emboli have been recorded twice each. There have been 20 instances of valvular dysfunction: 13 cases (15.7%) with intravalvular dysfunction, either proved at surgery (11 cases) or suggested by echocardiography (two cases). In five cases (6%) dysfunction has been due to a perivalvular leak. In two cases the mechanism of dysfunction has not been demonstrated. The most frequent causes of intravalvular dysfunction have been a tear-like rupture of an otherwise normal leaflet (five cases) and extensive valvular calcification (four cases). It is concluded that the very high rate of intravalvular dysfunction makes dura mater valves unsuitable for valvular replacement. |
| doi_str_mv | 10.1093/oxfordjournals.eurheartj.a061118 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75556646</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75556646</sourcerecordid><originalsourceid>FETCH-LOGICAL-c279t-bcff34b55571374ec01f052b2f65aa7f644889d4477e851d63f249c6c1b6fdc23</originalsourceid><addsrcrecordid>eNpVkF1LwzAUhoMoc05_gtAr8aYzSfPR3Cmim7qhF34Mb0KaJqyzXWfSjPnvjWwMvDoc3sPzHh4ALhEcIiiyq3ZjW1cu2uCWqvZDE9zcKNcthgoyhFB-APqIYpwKRugh6EMkaMpYPjsGJ94vIIQ5Q6wHehznVHDeB3Rqyio0SWdck1jVmaS1SRmcSpq4uGSt6nWolUuKql251ndz440_BUc29puz3RyAt_u719txOnkePdzeTFKNuejSQlubkYJSylHGidEQWUhxgS2jSnHLCMlzURLCuckpKllmMRGaaVQwW2qcDcDFlhurv4PxnWwqr01dq6Vpg5c8ohkjLB5ebw91_NE7Y-XKVY1yPxJB-WdO_jcn9-bkzlxEnO-6QtGYcg_YqYp5us0r35nNPlbuSzKecSrHs085fpyO3p9ehPzIfgHOQIM_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75556646</pqid></control><display><type>article</type><title>Medium term fate of dura mater valvular bioprostheses</title><source>MEDLINE</source><source>Oxford University Press Journals Digital Archive Legacy</source><creator>PERMANYER-MIRALDA, G. ; SOLER-SOLER, J. ; CASAN-CAVA, J. M. ; TORNOS-MAS, M. P.</creator><creatorcontrib>PERMANYER-MIRALDA, G. ; SOLER-SOLER, J. ; CASAN-CAVA, J. M. ; TORNOS-MAS, M. P.</creatorcontrib><description>Eighty-two patients have been followed for a mean period of 29 months after implantation of dura mater valvular bioprostheses (60 mitral valves, 30 aortic valves and two tricuspid valves). There have been three late deaths, two related to reoperation and one to endocarditis. Severe hemolysis, infective endocarditis and systemic emboli have been recorded twice each. There have been 20 instances of valvular dysfunction: 13 cases (15.7%) with intravalvular dysfunction, either proved at surgery (11 cases) or suggested by echocardiography (two cases). In five cases (6%) dysfunction has been due to a perivalvular leak. In two cases the mechanism of dysfunction has not been demonstrated. The most frequent causes of intravalvular dysfunction have been a tear-like rupture of an otherwise normal leaflet (five cases) and extensive valvular calcification (four cases). It is concluded that the very high rate of intravalvular dysfunction makes dura mater valves unsuitable for valvular replacement.</description><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1093/oxfordjournals.eurheartj.a061118</identifier><identifier>PMID: 7285977</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Adult ; Aged ; Aortic Valve - physiopathology ; Aortic Valve - surgery ; Bioprosthesis - adverse effects ; Calcinosis - etiology ; Dura Mater - surgery ; Dura mater valvular bioprostheses ; Embolism - etiology ; Endocarditis - etiology ; Endocarditis - mortality ; Heart Rupture - etiology ; Heart Valve Prosthesis - adverse effects ; heart valve replacement ; Heart Valves - physiopathology ; Heart Valves - surgery ; Humans ; intravalvular dysfunction ; Male ; Middle Aged ; Mitral Valve - physiopathology ; Mitral Valve - surgery ; Tricuspid Valve - physiopathology ; Tricuspid Valve - surgery</subject><ispartof>European heart journal, 1980-06, Vol.1 (3), p.195-199</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c279t-bcff34b55571374ec01f052b2f65aa7f644889d4477e851d63f249c6c1b6fdc23</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7285977$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>PERMANYER-MIRALDA, G.</creatorcontrib><creatorcontrib>SOLER-SOLER, J.</creatorcontrib><creatorcontrib>CASAN-CAVA, J. M.</creatorcontrib><creatorcontrib>TORNOS-MAS, M. P.</creatorcontrib><title>Medium term fate of dura mater valvular bioprostheses</title><title>European heart journal</title><addtitle>Eur Heart J</addtitle><description>Eighty-two patients have been followed for a mean period of 29 months after implantation of dura mater valvular bioprostheses (60 mitral valves, 30 aortic valves and two tricuspid valves). There have been three late deaths, two related to reoperation and one to endocarditis. Severe hemolysis, infective endocarditis and systemic emboli have been recorded twice each. There have been 20 instances of valvular dysfunction: 13 cases (15.7%) with intravalvular dysfunction, either proved at surgery (11 cases) or suggested by echocardiography (two cases). In five cases (6%) dysfunction has been due to a perivalvular leak. In two cases the mechanism of dysfunction has not been demonstrated. The most frequent causes of intravalvular dysfunction have been a tear-like rupture of an otherwise normal leaflet (five cases) and extensive valvular calcification (four cases). It is concluded that the very high rate of intravalvular dysfunction makes dura mater valves unsuitable for valvular replacement.</description><subject>Adult</subject><subject>Aged</subject><subject>Aortic Valve - physiopathology</subject><subject>Aortic Valve - surgery</subject><subject>Bioprosthesis - adverse effects</subject><subject>Calcinosis - etiology</subject><subject>Dura Mater - surgery</subject><subject>Dura mater valvular bioprostheses</subject><subject>Embolism - etiology</subject><subject>Endocarditis - etiology</subject><subject>Endocarditis - mortality</subject><subject>Heart Rupture - etiology</subject><subject>Heart Valve Prosthesis - adverse effects</subject><subject>heart valve replacement</subject><subject>Heart Valves - physiopathology</subject><subject>Heart Valves - surgery</subject><subject>Humans</subject><subject>intravalvular dysfunction</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mitral Valve - physiopathology</subject><subject>Mitral Valve - surgery</subject><subject>Tricuspid Valve - physiopathology</subject><subject>Tricuspid Valve - surgery</subject><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1980</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkF1LwzAUhoMoc05_gtAr8aYzSfPR3Cmim7qhF34Mb0KaJqyzXWfSjPnvjWwMvDoc3sPzHh4ALhEcIiiyq3ZjW1cu2uCWqvZDE9zcKNcthgoyhFB-APqIYpwKRugh6EMkaMpYPjsGJ94vIIQ5Q6wHehznVHDeB3Rqyio0SWdck1jVmaS1SRmcSpq4uGSt6nWolUuKql251ndz440_BUc29puz3RyAt_u719txOnkePdzeTFKNuejSQlubkYJSylHGidEQWUhxgS2jSnHLCMlzURLCuckpKllmMRGaaVQwW2qcDcDFlhurv4PxnWwqr01dq6Vpg5c8ohkjLB5ebw91_NE7Y-XKVY1yPxJB-WdO_jcn9-bkzlxEnO-6QtGYcg_YqYp5us0r35nNPlbuSzKecSrHs085fpyO3p9ehPzIfgHOQIM_</recordid><startdate>198006</startdate><enddate>198006</enddate><creator>PERMANYER-MIRALDA, G.</creator><creator>SOLER-SOLER, J.</creator><creator>CASAN-CAVA, J. M.</creator><creator>TORNOS-MAS, M. P.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198006</creationdate><title>Medium term fate of dura mater valvular bioprostheses</title><author>PERMANYER-MIRALDA, G. ; SOLER-SOLER, J. ; CASAN-CAVA, J. M. ; TORNOS-MAS, M. P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c279t-bcff34b55571374ec01f052b2f65aa7f644889d4477e851d63f249c6c1b6fdc23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1980</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aortic Valve - physiopathology</topic><topic>Aortic Valve - surgery</topic><topic>Bioprosthesis - adverse effects</topic><topic>Calcinosis - etiology</topic><topic>Dura Mater - surgery</topic><topic>Dura mater valvular bioprostheses</topic><topic>Embolism - etiology</topic><topic>Endocarditis - etiology</topic><topic>Endocarditis - mortality</topic><topic>Heart Rupture - etiology</topic><topic>Heart Valve Prosthesis - adverse effects</topic><topic>heart valve replacement</topic><topic>Heart Valves - physiopathology</topic><topic>Heart Valves - surgery</topic><topic>Humans</topic><topic>intravalvular dysfunction</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mitral Valve - physiopathology</topic><topic>Mitral Valve - surgery</topic><topic>Tricuspid Valve - physiopathology</topic><topic>Tricuspid Valve - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PERMANYER-MIRALDA, G.</creatorcontrib><creatorcontrib>SOLER-SOLER, J.</creatorcontrib><creatorcontrib>CASAN-CAVA, J. M.</creatorcontrib><creatorcontrib>TORNOS-MAS, M. P.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PERMANYER-MIRALDA, G.</au><au>SOLER-SOLER, J.</au><au>CASAN-CAVA, J. M.</au><au>TORNOS-MAS, M. P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Medium term fate of dura mater valvular bioprostheses</atitle><jtitle>European heart journal</jtitle><addtitle>Eur Heart J</addtitle><date>1980-06</date><risdate>1980</risdate><volume>1</volume><issue>3</issue><spage>195</spage><epage>199</epage><pages>195-199</pages><issn>0195-668X</issn><eissn>1522-9645</eissn><abstract>Eighty-two patients have been followed for a mean period of 29 months after implantation of dura mater valvular bioprostheses (60 mitral valves, 30 aortic valves and two tricuspid valves). There have been three late deaths, two related to reoperation and one to endocarditis. Severe hemolysis, infective endocarditis and systemic emboli have been recorded twice each. There have been 20 instances of valvular dysfunction: 13 cases (15.7%) with intravalvular dysfunction, either proved at surgery (11 cases) or suggested by echocardiography (two cases). In five cases (6%) dysfunction has been due to a perivalvular leak. In two cases the mechanism of dysfunction has not been demonstrated. The most frequent causes of intravalvular dysfunction have been a tear-like rupture of an otherwise normal leaflet (five cases) and extensive valvular calcification (four cases). It is concluded that the very high rate of intravalvular dysfunction makes dura mater valves unsuitable for valvular replacement.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>7285977</pmid><doi>10.1093/oxfordjournals.eurheartj.a061118</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0195-668X |
| ispartof | European heart journal, 1980-06, Vol.1 (3), p.195-199 |
| issn | 0195-668X 1522-9645 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_75556646 |
| source | MEDLINE; Oxford University Press Journals Digital Archive Legacy |
| subjects | Adult Aged Aortic Valve - physiopathology Aortic Valve - surgery Bioprosthesis - adverse effects Calcinosis - etiology Dura Mater - surgery Dura mater valvular bioprostheses Embolism - etiology Endocarditis - etiology Endocarditis - mortality Heart Rupture - etiology Heart Valve Prosthesis - adverse effects heart valve replacement Heart Valves - physiopathology Heart Valves - surgery Humans intravalvular dysfunction Male Middle Aged Mitral Valve - physiopathology Mitral Valve - surgery Tricuspid Valve - physiopathology Tricuspid Valve - surgery |
| title | Medium term fate of dura mater valvular bioprostheses |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T12%3A22%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Medium%20term%20fate%20of%20dura%20mater%20valvular%20bioprostheses&rft.jtitle=European%20heart%20journal&rft.au=PERMANYER-MIRALDA,%20G.&rft.date=1980-06&rft.volume=1&rft.issue=3&rft.spage=195&rft.epage=199&rft.pages=195-199&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1093/oxfordjournals.eurheartj.a061118&rft_dat=%3Cproquest_cross%3E75556646%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75556646&rft_id=info:pmid/7285977&rfr_iscdi=true |